Search
Patexia Community
News and Analysis

Our Members

All »
Tima Maslyuchenko
parham sameni
mike williams
MUHAMAD AZMAN MISKAM
Mehdi Sadaghdar
Valerio Vitale
j g shah shah
Kourosh Salehi
Mohamed Samir
R S
Keemia Kiani
shailendra Jain
Tooraj Rajabioun
Mehrdad Fatourechi
roham sameni

Innovation, Technology, and IP News

Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims

Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir. Sept. 15, 2023) In a decade-old case that has ...

Prosecution History May Support a Motivation to Combine

Written by: Rhett D. Ramsey & Jacob R. Rosenbaum Elekta Limited v. Zap Surgical Systems, Inc. Before: Reyna, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. ...

Landmark CAFC Cases in Patent Law: Shaping the Future of Innovation

In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the rules and precedents governing intellectual...

FDA Releases Draft Guidances on 510(k) Submissions

Written by: Paige L. Cappelli On September 6, 2023, the U.S. Food & Drug Administration (FDA) released three draft guidance documents to provide updated...

IPR Decision Based on a Barely Mentioned Typo Violated the APA Notice Requirement

Written by:Brianne M. Kingery & Daniel Kiang APPLE INC. v. COREPHOTONICS, LTD. Before Stoll, Linn, and Stark. Appeal from the Patent Trial and Appeal Board. Summary: An IPR...

Venture Capitalist Funding in Medtech Increasing
Knobbe Martens Sep 5, 2023
Written by: Christopher L. Lewis Recent reports, including one by PitchBook, indicate that both venture capitalist funding for... Read More »
Comment: 0 Favorite (0)
Fresh From the Bench: Latest Precedential Patent Case
Nika Aldrich Aug 31, 2023
CASE OF THE WEEK Volvo Penta of the Americas, LLC v. Brunswick Corp., Appeal No. 2022-1765 (Fed. Cir. Aug. 24, 2023) In its... Read More »
Comment: 0 Favorite (0)
A Terminal Disclaimer Is Not an Escape Hatch
Knobbe Martens Aug 30, 2023
Written by: Nefi R. Oliva & Nathan D. Reeves IN RE CELLECT, LLC Before Lourie, Dyk, and Reyna.  Appeal from the... Read More »
Comment: 0 Favorite (0)
Patexia Insight 185: From Flux to Surge: Is ANDA Litigation Rising?
Pedram Sameni Aug 30, 2023
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report. This year's report... Read More »
Comment: 0 Favorite (0)
Weighty Considerations: Objective Indicia of Non-obviousness
Knobbe Martens Aug 24, 2023
Written by: Alistair J. McIntyre & Brandon G. Smith Volvo Penta of the Americas, LLC, v. Brunswick Corp. Before Moore... Read More »
Comment: 0 Favorite (0)
Free Samples and Fillers: No Teaching Away or Commercial Success
Knobbe Martens Aug 24, 2023
Written by: Kenneth McNeill & Daniel P. Hughes INCEPT LLC v. PALETTE LIFE SCIENCES, INC. Before Newman, Schall, and... Read More »
Comment: 0 Favorite (0)
ANDA Litigation Resolutions: A Closer Look at Settlements and Their Consequences
Mikele Bicolli Aug 23, 2023
In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground... Read More »
Comment: 0 Favorite (0)
Fresh From the Bench: Latest Precedential Patent Case
Nika Aldrich Aug 21, 2023
CASE OF THE WEEK Incept LLC v. Palette Life Sciences, Inc., Appeal Nos. 2021-2063, -2065 (Fed. Cir. Aug. 16, 2023) In the... Read More »
Comment: 0 Favorite (0)
Navigating the Regulatory Landscape: FDA Approval and Patent Protection for Software as a Medical Device
Knobbe Martens Aug 21, 2023
Written by: Kenneth O. Aruda, Ph.D. Software is increasingly used as a medical device, transforming the healthcare industry with the... Read More »
Comment: 0 Favorite (0)
Patexia Insight 184: Major Lateral Moves of Patent Litigators in 2023
Pedram Sameni Aug 17, 2023
In January, we published the Patent Litigation 2023 Report analyzing all patent infringement cases filed in district courts during the period from... Read More »
Comment: 0 Favorite (0)
Generic vs. Brand Drug Approval: Unveiling Differences and Similarities under the Hatch-Waxman Act
Mikele Bicolli Aug 16, 2023
In the realm of pharmaceuticals, the approval process for generic and brand-name drugs holds significant importance. The Hatch-Waxman Act, ... Read More »
Comment: 0 Favorite (0)
Fresh From the Bench: Latest Precedential Patent Cases
Nika Aldrich Aug 14, 2023
CASE OF THE WEEK Axonics, Inc. v. Medtronic, Inc., Appeal Nos. 2022-1532, -1533 (Fed. Cir. Aug. 7, 2023) In this week’s ... Read More »
Comment: 0 Favorite (0)
Driving Success in PTAB Challenges: Patexia's Intelligence Report Shines a Spotlight on Leading Attorneys, Law Firms, and Companies
Mikele Bicolli Aug 11, 2023
In the dynamic realm of patent law, the Patent Trial and Appeal Board (PTAB) serves as a critical battleground for challenging the... Read More »
Comment: 0 Favorite (0)
FDA Statements and Patent Disclosures
Knobbe Martens Aug 11, 2023
Written by: Philip M. Nelson Medical Device companies often need the U.S. Food and Drug Administration (FDA) to approve... Read More »
Comment: 0 Favorite (0)
IPR Petitioners Must Be Permitted to Respond to Claim Constructions First Proposed in Patent Owner Response
Knobbe Martens Aug 9, 2023
Written by: Joshua C. Loader & Justin J. Gillett AXONICS, INC. v. MEDTRONIC, INC. Before Dyk, Lourie, and Taranto. Appeal... Read More »
Comment: 0 Favorite (0)
Navigating ANDA Litigation: Choosing the Best Attorneys and Law Firms
Mikele Bicolli Aug 9, 2023
Abbreviated New Drug Application (ANDA) litigation stands at the crossroads of pharmaceutical innovation and legal prowess. As generic... Read More »
Comment: 0 Favorite (0)
FDA Releases Draft Guidance for Studies of Medical Devices for Opioid Use Disorder
Knobbe Martens Aug 7, 2023
Written by: Joshua C. Loader The U.S. Food and Drug Administration (FDA) recently released draft guidance regarding clinical ... Read More »
Comment: 0 Favorite (0)
GlaxoSmithKline Challenges Pfizer's RSV Vaccine in High-Stakes Patent Lawsuit
Mikele Bicolli Aug 4, 2023
British drugmaker GlaxoSmithKline (GSK) has taken American pharmaceutical giant Pfizer to court, alleging a violation of its patent rights ... Read More »
Comment: 0 Favorite (0)
180-Day Exclusivity in Generic Drug Market: Understanding its Impact on Healthcare
Mikele Bicolli Aug 2, 2023
In the world of pharmaceuticals, access to affordable generic drugs is crucial for ensuring cost-effective healthcare solutions. The Drug... Read More »
Comment: 0 Favorite (0)
FDA Updates Medical Device Shortages List
Knobbe Martens Jul 27, 2023
Written by: Arash Pia The FDA has updated its Medical Device Shortages List to remove Specimen Collection, Laboratory... Read More »
Comment: 0 Favorite (0)
Show more Newsfeed posts
Menu